Napigen
1 known investors
Napigen develops technology for mitochondrial and chloroplast genome editing. The company operates in the biotechnology and genetic engineering sector.
Biotech
Investors · 1
In the news
- Napigen Advancing Organelle Genome Editing Technology for Crop Hybrid Seed Production | GenomeWebgenomeweb.com · 2022
- Genetics startup Napigen raises nearly $8Mdelawarebusinesstimes.com · 2022
- Organelle Genome Editing Startup Napigen Raises $7.9M | GenomeWebgenomeweb.com · 2022